Last updated on May 2020

Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)


Brief description of study

Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)

Clinical Study Identifier: NCT03790332

Find a site near you

Start Over

City of Hope

Duarte, CA United States
  Connect »

Rady Children's Hospital

San Diego, CA United States
  Connect »

Washington University

Saint Louis, MO United States
  Connect »

CHU Sainte-Justine

Montréal, QC Canada
  Connect »

Children's Hospital

Aurora, CO United States
  Connect »

CHU Sainte-Justine

Montréal, QC Canada
  Connect »

CHU Sainte-Justine

Montréal, QC Canada
  Connect »

CHU Sainte-Justine

Montréal, QC Canada
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

CHU Sainte-Justine

Montréal, QC Canada
  Connect »

University of California

San Francisco, CA United States
  Connect »

Johns Hopkins All Children's Hospital

Saint Petersburg, FL United States
  Connect »

CHU Sainte-Justine

Montréal, QC Canada
  Connect »

Seoul Saint Mary's Hospital

Seoul, Korea, Republic of
  Connect »

Primary Children's Hospital

Salt Lake City, UT United States
  Connect »

Medical College of Wisconsin

Milwaukee, WI United States
  Connect »

CHU Sainte-Justine

Montréal, QC Canada
  Connect »

Johns Hopkins University

Baltimore, MD United States
  Connect »